Genflow Biosciences (LON:GENF) has secured fresh funding and grant support to accelerate its gene therapy research, highlighting growing momentum in the longevity biotech space. With a blend of equity financing..
Full-year results highlight double-digit growth across key metrics, strengthened capital position, and continued M&A momentum, with a 6% dividend increase proposed...
Nuformix strengthens its NXP002 programme with US orphan drug designation, unlocking market exclusivity in a region accounting for the majority of IPF revenues. With fresh capital and ongoing partner discussions,..
Trustpilot has named Marcus Roy as Chief Financial Officer, effective September 2026. He joins from The Economist Group and will succeed long-serving CFO Hanno Damm, who will remain briefly to..
Kingfisher delivered modest sales growth and improved margins in FY 2025/26, supported by strong UK performance, expansion in trade and e-commerce, and disciplined cost control. Adjusted pre-tax profit rose 6%..
Corero reported FY 2025 revenue growth and a 23% rise in recurring revenue, driven by strong demand for its DDoS protection solutions and robust second-half performance...
KEFI has conditionally raised approximately £35.6 million through a placing, subscription, and RetailBook offer, including £941,574 from retail investors. The fundraising remains subject to shareholder approval in April 2026 and..
Net fee income rose 13% to £21.4m and underlying profit before tax reached £3.0m, reflecting broad-based sector growth, improved efficiency, and successful strategic investments...
Strong performance drove a rise in net assets and double-digit NAV total return, while shareholders benefited from a 21.9% total return. The Company also increased its dividend and strengthened its..
Latest drilling confirms wide, near-surface gold intersections at MB01 North, supporting resource growth potential and reinforcing Mbe as a multi-deposit project ahead of a maiden JORC estimate...
Fund manager Gervais Williams explains the trust’s long-term performance, the pressures from redemptions and discounts, and the rationale for offering shareholders a rollover into a multi-cap income fund...
Genflow Biosciences (LON:GENF) has secured fresh funding and grant support to accelerate its gene therapy research, highlighting growing momentum in the longevity biotech space. With a blend of equity financing and non-dilutive backing, the company is advancing its mission to tackle age-related diseases at the genetic level...
Full-year results highlight double-digit growth across key metrics, strengthened capital position, and continued M&A momentum, with a 6% dividend increase proposed...
Nuformix strengthens its NXP002 programme with US orphan drug designation, unlocking market exclusivity in a region accounting for the majority of IPF revenues. With fresh capital and ongoing partner discussions, the company is positioning itself to advance a differentiated inhaled therapy while negotiating from strength...
Trustpilot has named Marcus Roy as Chief Financial Officer, effective September 2026. He joins from The Economist Group and will succeed long-serving CFO Hanno Damm, who will remain briefly to support the transition...
Kingfisher delivered modest sales growth and improved margins in FY 2025/26, supported by strong UK performance, expansion in trade and e-commerce, and disciplined cost control. Adjusted pre-tax profit rose 6% and free cash flow remained solid, with further shareholder returns announced...
Corero reported FY 2025 revenue growth and a 23% rise in recurring revenue, driven by strong demand for its DDoS protection solutions and robust second-half performance...
KEFI has conditionally raised approximately £35.6 million through a placing, subscription, and RetailBook offer, including £941,574 from retail investors. The fundraising remains subject to shareholder approval in April 2026 and admission of new shares...
Net fee income rose 13% to £21.4m and underlying profit before tax reached £3.0m, reflecting broad-based sector growth, improved efficiency, and successful strategic investments...
Strong performance drove a rise in net assets and double-digit NAV total return, while shareholders benefited from a 21.9% total return. The Company also increased its dividend and strengthened its management structure for future growth...
Latest drilling confirms wide, near-surface gold intersections at MB01 North, supporting resource growth potential and reinforcing Mbe as a multi-deposit project ahead of a maiden JORC estimate...
Fund manager Gervais Williams explains the trust’s long-term performance, the pressures from redemptions and discounts, and the rationale for offering shareholders a rollover into a multi-cap income fund...
